Armata Pharmaceuticals (ARMP) Share-based Compensation Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.01% |
| Dec 31, 2025 | -6.02% |
| Sep 30, 2025 | -1.27% |
| Jun 30, 2025 | -8.69% |
| Mar 31, 2025 | -5.64% |
| Dec 31, 2024 | -19.48% |
| Sep 30, 2024 | -23.14% |
| Jun 30, 2024 | 13.02% |
| Mar 31, 2024 | 40.08% |
| Dec 31, 2023 | 187.08% |
| Sep 30, 2023 | -117.46% |
| Jun 30, 2023 | 82.20% |
| Mar 31, 2023 | 47.68% |
| Dec 31, 2022 | 43.99% |
| Sep 30, 2022 | 53.90% |
| Jun 30, 2022 | 25.99% |
| Mar 31, 2022 | 23.59% |
| Dec 31, 2021 | 17.46% |
| Sep 30, 2021 | 7.03% |
| Jun 30, 2021 | 10.60% |
| Mar 31, 2021 | 0.63% |
| Dec 31, 2020 | 30.24% |
| Sep 30, 2020 | 34.79% |
| Jun 30, 2020 | 77.10% |
| Mar 31, 2020 | 82.20% |
| Dec 31, 2019 | 76.54% |
| Sep 30, 2019 | 12.15% |
| Jun 30, 2019 | 25.24% |
| Mar 31, 2019 | -15.81% |
| Dec 31, 2018 | -14.87% |
| Sep 30, 2018 | 14.97% |
| Jun 30, 2018 | -57.68% |